UCART123

FDA lifts hold on Cellectis’ CAR-T trial, adds go-slow caveat
Fierce Biotech
Tue, 11/7/17 - 09:38 am
FDA
Cellectis
CAR-T
clinical trials
UCART123
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T
Xconomy
Tue, 09/5/17 - 09:50 am
FDA
Cellectis
CAR-T
UCART123
clinical trials
Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study
Endpoints
Sat, 08/19/17 - 10:29 am
Medvir
hepatitis C
China
Ascletis
Cellectis
UCART123
CAR-T